Evidence map›Paper›PMID 38906506›Full record

ReviewAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2025

Frailty in Kidney Disease: A Comprehensive Review to Advance Its Clinical and Research Applications.

Devika Nair, Christine K Liu, Rasha Raslan, Mara McAdams-DeMarco, Rasheeda K Hall

Abstract readReview
In one paragraph

Review in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Muscle Matters: Poor Muscle Quality Increases Mortality Risk in Early CKD.Clinical journal of the American Society of Nephrology : CJASN · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Review
  16. Review
  17. Article
  18. Observational
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Devika NairVanderbilt University Medical Center, Division of Nephrology and Hypertension, Nashville, Tennessee; Vanderbilt Center for Health Services Research, Nashville, Tennessee; Tennessee Valley Veterans Affairs Healthcare System, Nashville, Tennessee.
Christine K LiuGeriatric Research and Education Clinical Center, Veteran Affairs Palo Alto Health Care System, Palo Alto, California; Section of Geriatric Medicine, Division of Primary Care and Population Health, School of Medicine, Stanford University, Stanford, California.
Rasha RaslanDepartment of Medicine, School of Medicine, Duke University, Durham, North Carolina.
Mara McAdams-DeMarcoDepartment of Surgery, Langone Health and Grossman School of Medicine, New York University, New York, New York; Department of Population Health, Langone Health and Grossman School of Medicine, New York University, New York, New York.
Rasheeda K HallDepartment of Medicine, School of Medicine, Duke University, Durham, North Carolina; Durham Veterans Affairs Medical Center, Durham, North Carolina. Electronic address: Rasheeda.hall@duke.edu.

Funding

Structural Racism, Resilience, and Premature Cognitive Aging in End-Stage Renal Disease - Revision - 5R01AG077888 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Mara A. McAdams DeMarco · 2022 to 2026
$4.4M
Kidney transplantation in older, frail and cognitively impaired adults with ESRD: Balancing utility vs. justiceR01AG055781 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MCADAMS DEMARCO, MARA A. · 2017 to 2021
$4.2M
Hemodialysis-based interventions to preserve cognitive functionR01DK114074 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MCADAMS DEMARCO, MARA A. · 2018 to 2022
$3.9M
Virtually Supervised Exercise for Kidney Transplant CandidatesR01DK133509 · NIDDK · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI Christine Kee Liu · 2022 to 2026
$3.0M
Developing personalized immunosuppression for older kidney transplant recipientsR01DK120518 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MCADAMS DEMARCO, MARA A. · 2019 to 2022
$2.7M
Kidney Disease Aging Research Collaborative (KDARC) Research Infrastructure to Advance the Science of Geriatric NephrologyR61AG086824 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HALL, RASHEEDA K, MCADAMS DEMARCO, MARA A. · 2024 to 2025
$1.7M
Integration of Geriatric Care into Dialysis ClinicsR01AG076918 · NIA · DUKE UNIVERSITY · PI HALL, RASHEEDA K · 2023 to 2024
$1.6M
Deprescribing for Older Dialysis PatientsK76AG059930 · NIA · DUKE UNIVERSITY · PI HALL, RASHEEDA K · 2018 to 2022
$1.2M
Impact of climate change on cognitive and physical aging of older kidney transplant recipientsK02AG076883 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Mara A. McAdams DeMarco · 2023 to 2026
$728k
Activation for Self-Care Needs in Older Adults with Chronic Kidney Disease: ACTIVE SENIORS with CKDK23DK129774 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI NAIR, DEVIKA · 2022 to 2023
$351k
CSRD VA IK2 CX002595NIA NIH HHS K02 AG076883NIA NIH HHS K76 AG059930NIA NIH HHS R01 AG055781NIA NIH HHS R01 AG076918NIA NIH HHS R01 AG077888NIA NIH HHS R61 AG086824NIDDK NIH HHS K23 DK129774NIDDK NIH HHS R01 DK114074NIDDK NIH HHS R01 DK120518NIDDK NIH HHS R01 DK133509
6 · The paper itself

Abstract

Frailty is a multisystem syndrome of decreased physiologic reserve that has been shown to strongly and independently predict morbidity and mortality. Frailty is prevalent in patients living with kidney disease and occurs earlier in individuals with kidney disease as compared to the general population. In this comprehensive review, we examine clinical and research applications of frailty in kidney disease populations. Specifically, we clarify the definition of frailty and address common misconceptions, review the mechanisms and epidemiology of frailty in kidney disease, discuss challenges and limitations in frailty measurement, and provide updated evidence related to risk factors for frailty, its associated adverse outcomes, and interventions. We further add to the literature in this topic by highlighting the potential applications of frailty measurement in the care of patients with kidney disease and conclude with our recommendations for future research related to this important syndrome.

Indexed as

FrailtyBiomedical ResearchHumansKidney DiseasesRisk FactorsAgingfrailtygeriatricskidney diseaseolder adults

Identifiers

PMID38906506
PMCPMC11655709

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.